Country for PR: United Kingdom
Contributor: PR Newswire Europe
Wednesday, November 25 2020 - 09:00
Almirall announces collaborations with the University of South Australia and FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
BARCELONA, Spain, Nov. 25, 2020 /PRNewswire/ AsiaNet/ --

    AlmirallShare [], the open innovation 
platform of Almirall, S.A. (ALM) [], announces two new 
collaborations with the University of South Australia and the Fundació Institut 
de Recerca de l'Hospital de la Santa Creu i Sant Pau to find new pathways for 
the treatment of skin cancer and atopic dermatitis. 

    The collaboration with Prof. Tarl Prow, Research Professor at Future 
Industries Institute of the University of South Australia, is focused on 
generating knowledge about a common type of skin tumor. The aim is to elucidate 
the molecular mechanisms underlying squamous cell carcinoma and the modulation 
by a specific treatment. "We are excited to be joining forces with Almirall in 
this collaborative research project that allows us to establish synergies 
between different groups to follow our commitment to fight skin cancer. Pairing 
our deep knowledge of a common type of skin tumor with Almirall's leading 
expertise in medical dermatology could reimagine the treatment options for 
people with skin carcinoma," said Prof. Tarl Prow. 

    The project led by Prof. Dr. Lluís Puig, Director of Dermatology 
Department, and Prof. Silvia Vidal, Coordinator of Inflammatory Diseases 
Research Area, at Hospital de la Santa Creu i Sant Pau will focus on the 
understanding of biosignatures operating in atopic dermatitis in the different 
stages of the disease and in response to systemic therapy. "We strongly believe 
that this collaboration will boost new findings on atopic dermatitis, and it is 
a further step in future research on new treatments. We are very pleased to be 
joining forces with a leading medical dermatology company like Almirall," 
stated Prof. Dr. Lluís Puig and Prof. Silvia Vidal.

    "We are very pleased to start with these two new collaborations and 
establish close successful partnerships with them. We continue working to 
empower scientists to improve skin health and fostering collaboration projects 
with partners worldwide to make a real difference for patients living with skin 
conditions," said Maribel Crespo, AlmirallShare leader.

    AlmirallShare is responsible for approximately 50% of the private-public 
collaborations driven by Almirall. It facilitates collaborations in 
dermatological research and accelerate the generation of new treatments for 
skin conditions. Scientists from anywhere in the world may submit their 
proposals to submit their proposals responding to the current open calls on 

    Source: Almirall, S.A.